Dawei Ma
4 Papers
7 Citations
Dawei Ma is an academic researcher. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Patent
Compound for preparing nifeviroc and its preparing process
Dawei Ma,Ben Li,Shanghai Yu,Li Chen,Huatian Ye,Hongjie Li,Zuxin Mei,Gao Jun +7 more
- 01 Aug 2007
TL;DR: In this article, a compound and its preparation process is described, wherein the compound can be used for preparing medicament capable of effectively inhibiting or resisting HIV virus (such as HIV-I virus).
3
Patent
Compounds as CCR5 antagonists
Gang Pei,Dawei Ma,Li Chen,Shanghai Yu,Ben Li,Fang Dong,Yanhui Lv,Renhai Chen,Jin Zhang +8 more
- 06 Dec 2006
TL;DR: In this article, the compounds of formula I or their pharmaceutically acceptable salts, which are useful as CCR5 antagonists, were disclosed and the preparation and use of a pharmaceutical composition containing the same compounds were also disclosed.
2
Patent
Compounds as cor5 antagonists
Gang Pei,Dawei Ma,Li Chen,Shanghai Yu,Ben Li,Fang Dong,Yanhui Lv,Renhai Chen,Jin Zhang +8 more
- 12 May 2005
TL;DR: In this article, the compounds of formula I or their pharmaceutically acceptable salts, which are useful as CCR5 antagonists, were disclosed and the preparation and use of a pharmaceutical composition containing the same compounds were also disclosed.
2
Patent
Composes utilises comme antagonistes de ccr5
Gang Pei,Dawei Ma,Li Chen,Shanghai Yu,Ben Li,Fang Dong,Yanhui Lv,Renhai Chen,Jin Zhang +8 more
- 12 May 2005
TL;DR: The authors concerne des composes representes par la formule (I) ou leurs sels acceptables sur le plan pharmaceutique, qui sont utiles comme antagonistes de CCR5.